Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: �Patients of both genders above 18 years & below 30 years with acne vulgaris. �Not receiving any systemic or topical acne treatment for last 2 weeks. �No tendency to develop keloid or hypertrophic scar. �Not receiving topical and systemic steroids for last 6 months. �Patients willing to give a written informed consent
Exclusion criteria
Exclusion criteria: Before starting the study �Pregnant and lactating women. �Women planning for pregnancy �Patients with co-morbidities-DM,SHT,TB,CAD,EPILEPSY,BA,HIV During Study �If patient develops severe side effects during the treatment �If patient wants alternate treatment during the study. �If patient wants to discontinue the treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The end point will be the evaluation of clinical response to both the mode of treatment at 16 weeks after treatment initiation. Responses in between the study will be noticed & recorded using Comprehensive Acne Severity Scale(CASS) and patient satisfaction scoreTimepoint: 16 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To look for reduction of post acne pigmentation following treatment and recurrenceTimepoint: 8 weeks | — |
Countries
India
Contacts
Chengalpattu Medical College